New diabetes clinical trial: Efficacy and Safety of Wharton's Jelly-Derived Mesenchymal Stem Cell Exosomes in the Treatment of Diabetic Foot Ulcers: a Randomized Controlled Trial

Published on: February 05, 2025 at 11:00PM
Conditions: Diabetic Foot Ulcer (DFU); Exosomes
Interventions: Drug: WJ-MSC- Exosomes; Combination Product: SOC (Standard of care); Other: Vehicle (placebo)
Sponsors: Kafrelsheikh University
Completed
https://ift.tt/sxhIQVW